Start Date
May 31, 2001
Primary Completion Date
April 30, 2003
Study Completion Date
December 31, 2010
FOLFOX regimen
fluorouracil
leucovorin calcium
oxaliplatin
New York University Medical Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Albert Einstein Comprehensive Cancer Center, The Bronx
New York Medical College, Valhalla
HemOnCare, P.C., Brooklyn
South Shore Hematology Oncology Associates, P.C., Rockville Centre
North Shore Hematology/Oncology Associates, P.C., East Setauket
Reddy Cancer Treatment Center, Malone
Interlakes Oncology/Hematology PC, Rochester
University of Rochester Medical Center, Rochester
Oncology Hematology of Lehigh Valley, P.C., Bethlehem
Pennsylvania Oncology Hematology Associates, Philadelphia
Lombardi Cancer Center, Washington D.C.
Halifax Medical Center, Daytona Beach
Hematology/Oncology Associates, Jacksonville
Florida Hospital Cancer Institute, Orlando
Oncology-Hematology Group of South Florida, Miami
Center for Hematology-Oncology, Boca Raton
Florida Cancer Specialists, Fort Myers
Lake Heart and Cancer Medical Center, Leesburg
Hematology/Oncology Associates, Port Saint Lucie
Memorial Hospital Cancer Center - Chattanooga, Chattanooga
Baptist Regional Cancer Center, Knoxville
Family Cancer Center, Collierville
West Cancer Clinic, Memphis
Jackson Oncology Associates, PLLC, Jackson
Medical Oncology Group, Gulfport
James Graham Brown Cancer Center, Louisville
Mid-Ohio Oncology/Hematology, Inc., Columbus
Hematology Oncology Consultants Inc, Columbus
Lawrence M. Stallings Medical Practice, Wooster
Hope Center, Terre Haute
Saint Joseph Mercy Hospital, Ann Arbor
Medical Oncology and Hematology Associates, Des Moines
Mercy Cancer Center, Mason City
Northwest Medical Specialists, P.C., Arlington Heights
Dreyer Medical Clinic, Aurora
Cancer Care Specialists of Central Illinois, S.C., Decatur
St. Joseph Oncology, Inc., Saint Joseph
Cancer and Blood Institute, Metairie
Arkansas Cancer Clinic, P.A., Pine Bluff
Oklahoma Oncology Inc., Tulsa
Center for Oncology Research and Treatment, Medical City Hospital, Dallas
Scott and White Memorial Hospital, Temple
Cancer Therapy and Research Center, San Antonio
Rocky Mountain Cancer Center, Denver
Huntsman Cancer Institute, Salt Lake City
Intermountain Hematology/Oncology Associates, Inc., Salt Lake City
Arizona Clinical Research Center, Tucson
University of New Mexico Cancer Research & Treatment Center, Albuquerque
Cedars-Sinai Medical Center, Los Angeles
Kenmar Research Institute, Los Angeles
Kaiser Permanente-Southern California Permanente Medical Group, San Diego
Comprehensive Cancer Centers of the Desert, Palm Springs
Citrus Valley Medical Center, Covina
Kaiser Permanente Medical Center - Vallejo, Vallejo
John Muir Medical Center, Walnut Creek
California Cancer Care, Inc., Greenbrae
Bend Memorial Clinic, Bend
Seattle Cancer Care Alliance, Seattle
Cancer Center and Beckman Research Institute, City of Hope, Duarte
Northwestern Connecticut Oncology-Hematology Associates, Torrington
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Lucille Parker Markey Cancer Center, University of Kentucky, Lexington
Baton Rouge General Medical Center, Baton Rouge
Saints Memorial Medical Center, Lowell
Deaconess Billings Clinic, Billings
Monmouth Medical Center, Long Branch
Jersey Shore Cancer Center, Neptune City
Central Jersey Oncology Center, New Brunswick
Hematology Associates of New Jersey, P.A., Ridgewood
Monmouth Hematology-Oncology Associates, P.A., West Long Branch
Salem Hospital Regional Cancer Center, Salem
Lifespan: The Miriam Hospital, Providence
Prologue Research International
INDUSTRY